Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Patient Preference for Biopsy Notification

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02213471
Recruitment Status : Completed
First Posted : August 11, 2014
Last Update Posted : August 11, 2014
Sponsor:
Information provided by (Responsible Party):
Maria Wei, University of California, San Francisco

Brief Summary:
Effective communication between physician and patient is fundamental to effective care. The recent introduction of electronic patient on-line portals has the potential to change the communication landscape. The investigators surveyed patients to assess their preferred modality for biopsy notification at 3 institutions with differing patient access to on-line portals, to ascertain what patient preferences are currently and if it has changed from historical preferences. Our hypothesis is that as patients become more familiar with ln-line portals, their preferences will likely reflect familiarity with this modality.

Condition or disease
Elevated Risk for Melanoma

Layout table for study information
Study Type : Observational
Actual Enrollment : 301 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Patient Preference for Biopsy Notification
Study Start Date : July 2012
Actual Primary Completion Date : July 2013
Actual Study Completion Date : July 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Biopsy Melanoma

Group/Cohort
Elevated risk for melanoma
Individuals at increased risk for melanoma due to past history of melanoma, family history of melanoma, the presence of many moles, the presence of a genetic mutation known to increase the risk of melanoma.



Primary Outcome Measures :
  1. Patient preference for biopsy notification [ Time Frame: 1 year ]
    Patients were asked to rank in order of preference their preferred method for being notified of a skin biopsy result



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Individuals at increased risk for melanoma due to past history of melanoma, family history of melanoma, the presence of many moles, the presence of a genetic mutation known to increase the risk of melanoma. Individuals were followed in a Pigmented Lesion Clinic.
Criteria

Inclusion Criteria:

  • Patients who were 18 years of age or older and English speaking were eligible to participate

Exclusion Criteria:

  • Younger than 18, non-English speaking.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02213471


Locations
Layout table for location information
United States, California
University of California
San Francisco, California, United States, 94115
Sponsors and Collaborators
Maria Wei
Investigators
Layout table for investigator information
Principal Investigator: Maria L Wei, MD PhD University of California, San Francisco

Layout table for additonal information
Responsible Party: Maria Wei, Associate Professor of Dermatology, University of California, San Francisco
ClinicalTrials.gov Identifier: NCT02213471     History of Changes
Other Study ID Numbers: BX001
First Posted: August 11, 2014    Key Record Dates
Last Update Posted: August 11, 2014
Last Verified: August 2014
Additional relevant MeSH terms:
Layout table for MeSH terms
Melanoma
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Nerve Tissue
Nevi and Melanomas